Multi-omics integration reveals CYTL1 and H6PD as key regulators of tumor metabolism in mesothelioma
{{output}}
Background: Mesothelioma is a rare and aggressive cancer with limited therapeutic options and poor prognosis. Despite advancements in understanding its molecular mechanisms, effective biomarkers and therapeutic targets remain elu... ...
